ClinicalTrials.Veeva

Menu

SMS Reminders to Strengthen Demand for HPV Vaccination in Georgia

T

The Behavioural Insights Team

Status

Not yet enrolling

Conditions

HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine

Treatments

Behavioral: SMS reminder for the HPV vaccination

Study type

Interventional

Funder types

Other

Identifiers

NCT05536674
UNICEF Georgia 2020021

Details and patient eligibility

About

It is possible that achieving adequate HPV vaccination coverage will allow cervical cancer to be virtually eliminated. This is a priority for Georgia, where the burden of mortality and morbidity from cervical cancer is high and the yearly prevalence of cervical cancer is 14.5 per 100,000 population.

The objective of the intervention evaluated is to increase the uptake of the 1st dose of the HPV vaccination in Georgia. The intervention aims to achieve this by providing a SMS reminder informed by behavioural insights (BI) to remind caregivers of girls between 10-12 years that their daughter is due the first dose of her HPV vaccination, share information about the vaccine, and encourage them to book an appointment to receive the vaccination. Four different SMS messages will be compared to no SMS message.

The evaluation will be a 5-arm randomised controlled trial (RCT) which aims to answer the research question: Does each of the designed BI-informed SMS reminders increase the uptake of the first dose of the HPV vaccination among eligible girls in Georgia, compared to no reminder? Our hypothesis is that SMS reminders will increase the uptake of HPV vaccination.

Enrollment

55,176 estimated patients

Sex

Female

Ages

10 to 12 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Girls
  • Aged 10-12 years
  • Not yet received any doses of the HPV vaccine
  • With a caregiver's mobile phone number in the e-health system.

Exclusion criteria

  • Boys
  • Girls aged less than 10 or more than 12 years
  • Girls with no caregiver phone number in the e-health system
  • Girls who have received 1 or 2 doses of the HPV vaccine

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

55,176 participants in 5 patient groups

No SMS reminder
No Intervention group
Description:
This group will receive no reminder
Short SMS with no additional information
Experimental group
Description:
Caregivers of girls eligible to receive the HPV vaccination in this group will receive an SMS reminder that states: "As per national immunization calendar your daughter is due her free human papilloma virus vaccine, which will protect her against cervical cancer. Contact your family doctor today to arrange an appointment."
Treatment:
Behavioral: SMS reminder for the HPV vaccination
Short SMS + NCDC link
Experimental group
Description:
Caregivers of girls eligible to receive the HPV vaccination in this group will receive an SMS reminder that states: "As per national immunization calendar your daughter is due her free human papilloma virus vaccine, which will protect her against cervical cancer. Contact your family doctor today to arrange an appointment. More information on the official NCDC website"
Treatment:
Behavioral: SMS reminder for the HPV vaccination
SMS with "reserved for her" framing + NCDC link
Experimental group
Description:
Caregivers of girls eligible to receive the HPV vaccination in this group will receive an SMS reminder that states: "As per national immunization calendar your daughter is due her free human papilloma virus vaccine, which will protect her against cervical cancer. Her vaccine is reserved at the policlinic. Contact your family doctor today to arrange an appointment. More information on the official NCDC website"
Treatment:
Behavioral: SMS reminder for the HPV vaccination
SMS with safety information + NCDC link
Experimental group
Description:
Caregivers of girls eligible to receive the HPV vaccination in this group will receive an SMS reminder that states: "As per national immunization calendar your daughter is due her free human papilloma virus vaccine, which will protect her against cervical cancer. The vaccine has been given safely to more than 118 million girls worldwide. Contact your family doctor today to arrange an appointment. More information on the official NCDC website"
Treatment:
Behavioral: SMS reminder for the HPV vaccination

Trial contacts and locations

0

Loading...

Central trial contact

Clement Bisserbe; Zara Y Goozee

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems